|
⚲
|
| Keyboard |
| Paradigm Biocapital Advisors LP
✚
|
|
|---|---|
| CRD # | 312544 |
| SEC # | 801-120338 |
| CIK # | 0001855655 |
| AUM | 4,469.2 M (2026-05-27) |
| Employees | 11 (55% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 646-970-2568 |
| Address | 520 Fifth Avenue New York, NY 10036 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001855655 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Revolution Medicines Inc | 0.6 | ||
| Nuvalent Inc | 0.5 | ||
| Vaxcyte Inc | 0.3 | ||
| Edgewise Therapeutics Inc | 0.2 | ||
| Genmab A/S | 0.2 | ||
| Insmed Inc | 0.2 | ||
| Tarsus Pharmaceuticals Inc | 0.2 | ||
| Belite Bio Inc | 0.2 | ||
| Erasca Inc | 0.2 | ||
| Olema Pharmaceuticals Inc | 0.1 | ||
| ARCA Biopharma Inc | 0.1 | ||
| Apogee Therapeutics Inc | 0.1 | ||
| Aeglea Biotherapeutics Inc | 0.1 | ||
| Cytokinetics Inc | 0.1 | ||
| Abivax Sa | 0.1 | ||
| BCTG Acquisition Corp | 0.1 | ||
| MAZE Therapeutics Inc | 0.1 | ||
| TYRA Biosciences Inc | 0.1 | ||
| Signal Genetics Inc | 0.1 | ||
| Scholar Rock Holding Corp | 0.1 | ||
| Mirum Pharmaceuticals Inc | 0.1 | ||
| Psivida Corp | 0.0 | ||
| Lexeo Therapeutics Inc | 0.0 | ||
| Veradermics Inc | 0.0 | ||
| Vor Biopharma Inc | 0.0 | ||
| UroGen Pharma Ltd | 0.0 | ||
| Structure Therapeutics Inc | 0.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Paradigm Biocapital International Fund Ltd | [2021-06-23] | 105.3 M | 4,004.1 M |
| Filed 2025-04-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 4.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 0.5 |
| Total | 4 | 4.5 |
| By Discretionary | ||
| Discretionary | 4 | 4.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 4.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 4.0 | |
| United States Persons | 0.5 | |
| Total | 4 | 4.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Senai Asefaw | Executive Officer | 3 | 2 | |
| Paradigm Biocapital GP LLC | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001855655] | |
| 3 | [0001855655] | |
| 4 | [0001855655] | |
| SC 13G | [0001855655] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300I649YOM8XI0E93 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Olema Pharmaceuticals Inc | |
| Asefaw Senai | |
| Paradigm BioCapital Advisors GP LLC | |
| Paradigm BioCapital International Fund Ltd | |
| Paradigm Biocapital Advisors LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2024-08-01 | Sell | 529,501 | $14.92 | 7,900,155 |
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2024-08-01 | Sell | 1,870,499 | $14.92 | 27,907,845 |
|
Olema Pharmaceuticals Inc OLMA
Common Stock, par value $0.0001 per share
|
2023-12-06 | Buy | 100,000 | $11.60 | 1,160,000 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Dwight Securities Management LLC
✚
|
FL | 4,555.8 M |
|
Conifer Management LLC
✚
|
NY | 4,531.5 M |
|
Hawk Ridge Capital Management LP
✚
|
CA | 4,528.0 M |
|
Performa Limited US LLC
✚
|
SC | 4,491.2 M |
|
Elementum Advisors LLC
✚
|
IL | 4,475.9 M |
|
Bluespruce Investments LP
✚
|
IL | 4,454.3 M |
|
Valley Forge Capital Management LP
✚
|
FL | 4,447.8 M |
|
Locust Wood Capital Advisers LLC
✚
|
NY | 4,395.9 M |
|
AQR Arbitrage LLC
✚
|
CT | 4,384.1 M |
|
RWC Asset Advisors US LLC
✚
|
FL | 4,380.3 M |